Stem Cell Therapies in the Treatment of Disc-Related Low Back Pain

<p>Moderator Douglas Pahl, MD, interviews authors Alex Mierke, MD, and Omar Ramos, MD, about their article titled, "Stem Cell Therapies in the Treatment of Disc-Related Low Back Pain." Drs. Mierke and Ramos discuss what is already known about stem cell therapies and what still may lie ahead in this ever-changing medical landscape.</p> <p>Access the <a href="http://www.spineline-digital.org/spineline/july_august_2020/MobilePagedReplica.action?pm=2&amp;folio=12#pg14" title="http://www.spineline-digital.org/spineline/july_august_2020/MobilePagedReplica.action?pm=2&amp;folio=12#pg14">article here</a>.</p> <p><br></p> <p>Disclosures:</p> <p>Mierke, Alex : Nothing to Disclose &nbsp;</p> <p>Pahl, Douglas W.: Consulting: Stryker (C, Outside 12-Month Requirement, Paid directly to institution/employer); Other: Orthofix (A, Outside 12-Month Requirement); Stock Ownership: Nanovis (14,837 Shares, Paid directly to institution/employer), Trainer Rx (&lt;1%), Vertera (D, Paid directly to institution/employer); Trips/Travel: Astrazeneca (A, Outside 12-Month Requirement), Boston Scientific (B, Outside 12-Month Requirement), DePuy/Synthes (A, Outside 12-Month Requirement), DJO (A, Outside 12-Month Requirement), Globus (A, Outside 12-Month Requirement), Horizon (A, Outside 12-Month Requirement), Medtronic (A, Outside 12-Month Requirement), Stryker (B, Outside 12-Month Requirement), Zimmer/Biomet (C, Outside 12-Month Requirement).</p> <p>Ramos, Omar: Nothing to Disclose</p>